Literature DB >> 16086953

Diamond burr treatment of poor vision from anterior basement membrane dystrophy.

Patrick F Tzelikis1, Christopher J Rapuano, Kristin M Hammersmith, Peter R Laibson, Elisabeth J Cohen.   

Abstract

PURPOSE: To determine the outcome of patients with decreased vision associated with anterior basement membrane dystrophy (ABMD) managed with diamond burr (DB) polishing.
DESIGN: Retrospective nonrandomized case series.
METHODS: A chart review of all patients with ABMD who underwent epithelial debridement and DB polishing to treat visual disturbances resulting from corneal epithelial irregularity was performed.
RESULTS: Ten patients' charts were analyzed. The mean age was 57.4 years. DB treatment was performed in 13 eyes. The average preoperative BCVA was 0.40 (20/50). At the last follow-up (mean 21.8 months) the average visual acuity of these patients was 0.88 (20/23), significantly better than pre-operative readings (P < .001). There was no recurrence of dystrophic changes in the treatment zone seen with the slit lamp during the follow-up period.
CONCLUSIONS: In this study, DB polishing was shown to be an effective and safe treatment for decreased vision caused by to ABMD over an average follow-up of 21.8 months.

Entities:  

Mesh:

Year:  2005        PMID: 16086953     DOI: 10.1016/j.ajo.2005.01.036

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

Review 1.  Superficial Keratectomy: A Review of Literature.

Authors:  Farhad Salari; Alireza Beikmarzehei; George Liu; Mehran Zarei-Ghanavati; Christopher Liu
Journal:  Front Med (Lausanne)       Date:  2022-07-06

2.  Phototherapeutic keratectomy for epithelial basement membrane dystrophy.

Authors:  Wen-Shin Lee; Carson K Lam; Edward E Manche
Journal:  Clin Ophthalmol       Date:  2016-12-16

3.  Treatment of Epithelial Basement Membrane Dystrophy to Optimize the Ocular Surface Prior to Cataract Surgery.

Authors:  Elizabeth Yeu; Omar Hashem; Hosam Sheha
Journal:  Clin Ophthalmol       Date:  2022-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.